Anavex Life Sciences
AVXL
#7563
Rank
โ‚น35.31 B
Marketcap
โ‚น395.28
Share price
-1.12%
Change (1 day)
-38.58%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -โ‚น48.51

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -โ‚น51.21. In 2024 the company made an earnings per share (EPS) of -โ‚น46.71 an increase over its 2023 EPS that were of -โ‚น53.90.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น48.513.84%
2024-โ‚น46.71-13.33%
2023-โ‚น53.90-3.23%
2022-โ‚น55.7014.81%
2021-โ‚น48.5120%
2020-โ‚น40.43-16.67%
2019-โ‚น48.5138.46%
2018-โ‚น35.0418.18%
2017-โ‚น29.65-21.43%
2016-โ‚น37.73-35.38%
2015-โ‚น58.39-36.27%
2014-โ‚น91.63112.5%
2013-โ‚น43.12-58.62%
2012-โ‚น104.21-0%
2011-โ‚น104.21-29.27%
2010-โ‚น147.3351.85%
2009-โ‚น97.02-0%
2008-โ‚น97.02237.5%
2007-โ‚น28.75
2006N/A-100%
2005-โ‚น3.59499.97%
2004-โ‚น0.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น214.71-519.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น4.49-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น89.84-275.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น5,480 10,601.75%๐Ÿ‡บ๐Ÿ‡ธ USA